High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels. (2019)
Attributed to:
MICA: Immuno-psychiatry: a consortium to test the opportunity for immunotherapeutics in psychiatry
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41398-019-0633-0
PubMed Identifier: 31745072
Publication URI: http://europepmc.org/abstract/MED/31745072
Type: Journal Article/Review
Volume: 9
Parent Publication: Translational psychiatry
Issue: 1
ISSN: 2158-3188